CN111544525A - Traditional Chinese medicine external preparation for treating bone diseases - Google Patents
Traditional Chinese medicine external preparation for treating bone diseases Download PDFInfo
- Publication number
- CN111544525A CN111544525A CN202010518591.7A CN202010518591A CN111544525A CN 111544525 A CN111544525 A CN 111544525A CN 202010518591 A CN202010518591 A CN 202010518591A CN 111544525 A CN111544525 A CN 111544525A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- bone diseases
- treating bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 208000020084 Bone disease Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 241001313857 Bletilla striata Species 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 9
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 7
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000012856 weighed raw material Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000036407 pain Effects 0.000 abstract description 16
- 230000008961 swelling Effects 0.000 abstract description 12
- 208000032843 Hemorrhage Diseases 0.000 abstract description 10
- 208000014674 injury Diseases 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 8
- 210000000988 bone and bone Anatomy 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000035876 healing Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010024453 Ligament sprain Diseases 0.000 abstract description 5
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 5
- 208000010040 Sprains and Strains Diseases 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 5
- 208000005801 spondylosis Diseases 0.000 abstract description 5
- 210000002435 tendon Anatomy 0.000 abstract description 5
- 230000008736 traumatic injury Effects 0.000 abstract description 5
- 208000010392 Bone Fractures Diseases 0.000 abstract description 4
- 206010017076 Fracture Diseases 0.000 abstract description 4
- 208000012287 Prolapse Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicine external preparation for treating bone diseases comprises the following traditional Chinese medicine raw materials in parts by weight: 5-8 parts of paris rhizome, 3-6 parts of angelica dahurica, 3-5 parts of bletilla striata, 2-4 parts of borneol and 5-8 parts of pseudo-ginseng. The rhizoma paridis is prepared by processing rhizoma paridis with wine. The rhizoma Bletillae is processed rhizoma Bletillae. Through reasonable matching of the raw materials of the components, the traditional Chinese medicine composition is beneficial to clearing heat and reducing swelling, stopping bleeding and pain, and promoting blood circulation to remove blood stasis, thereby promoting bone healing. Is suitable for use in: prolapse of lumbar intervertebral disc, cervical spondylosis, fall, sprain, traumatic injury, fracture of tendons, and hemorrhage due to knife wound.
Description
Technical Field
The invention relates to a traditional Chinese medicine external preparation for treating bone diseases.
Background
The bone diseases are the most common diseases in the orthopedics diseases and comprise lumbar disc herniation, cervical spondylosis, falling and sprain, traumatic injury, broken tendons and fractures and other diseases. There are various methods for treating the osteopathy, but a preparation which can be taken orally and applied externally and is suitable for various osteopathia is lacked.
Disclosure of Invention
In view of the above circumstances, the present invention provides a Chinese medicinal external preparation for treating bone diseases, which solves the problems of the prior art.
A traditional Chinese medicine external preparation for treating bone diseases comprises the following traditional Chinese medicine raw materials in parts by weight: 5-8 parts of paris rhizome, 3-6 parts of angelica dahurica, 3-5 parts of bletilla striata, 2-4 parts of borneol and 5-8 parts of pseudo-ginseng.
The traditional Chinese medicine external preparation for treating bone diseases comprises the following traditional Chinese medicine raw materials in parts by weight: 5 parts of paris rhizome, 3 parts of angelica dahurica, 5 parts of bletilla striata, 2 parts of borneol and 5 parts of pseudo-ginseng.
According to the external traditional Chinese medicine preparation for treating bone diseases, the paris rhizome is prepared by processing paris rhizome with wine.
According to the application, the bletilla striata is prepared.
The application method of the traditional Chinese medicine external preparation for treating bone diseases comprises the following steps: weighing the raw medicinal materials according to the weight ratio of each component; putting the weighed raw materials of each component into a container respectively, completely crushing the raw materials into powder, putting the crushed mixed medicine into the container, and sealing.
The application method of the traditional Chinese medicine external preparation for treating bone diseases further comprises the following steps: when in use, honey or warm water is added into the mixture and stirred to form gel, and the traditional Chinese medicine external preparation for treating bone diseases is obtained.
After the technology provided by the invention is adopted, the traditional Chinese medicine external preparation for treating bone diseases provided by the embodiment of the invention has the following beneficial effects.
1) Through reasonable matching of the raw materials of the components, the traditional Chinese medicine composition is beneficial to clearing heat and reducing swelling, stopping bleeding and pain, and promoting blood circulation to remove blood stasis, thereby promoting bone healing. Is suitable for use in: prolapse of lumbar intervertebral disc, cervical spondylosis, fall, sprain, traumatic injury, fracture of tendons, and hemorrhage due to knife wound.
Detailed Description
Various preferred embodiments of the present invention will be described below. The following description is provided to facilitate understanding of example embodiments of the invention as defined by the claims and their equivalents. It includes various specific details to assist understanding, but they are to be construed as merely illustrative. Accordingly, those skilled in the art will recognize that various changes and modifications can be made to the embodiments described herein without departing from the scope and spirit of the present invention. Also, in order to make the description clearer and simpler, a detailed description of functions well known in the art will be omitted.
Example 1
A traditional Chinese medicine external preparation for treating bone diseases comprises the following traditional Chinese medicine raw materials in parts by weight: 5-8 parts of paris rhizome, 3-6 parts of angelica dahurica, 3-5 parts of bletilla striata, 2-4 parts of borneol and 5-8 parts of pseudo-ginseng.
The rhizoma paridis is prepared by processing rhizoma paridis with wine.
The rhizoma Bletillae is processed rhizoma Bletillae.
The application method of the traditional Chinese medicine external preparation for treating bone diseases comprises the following steps: weighing the raw medicinal materials according to the weight ratio of each component; putting the weighed raw materials of each component into a container respectively, completely crushing the raw materials into powder, putting the crushed mixed medicine into the container, and sealing.
The application method of the traditional Chinese medicine external preparation for treating bone diseases further comprises the following steps: when in use, honey or warm water is added into the mixture and stirred to form gel, and the traditional Chinese medicine external preparation for treating bone diseases is obtained.
According to the traditional Chinese medicine external preparation for treating bone diseases, the properties and effects of the used traditional Chinese medicine raw materials are as follows: paris rhizome: cool, has the efficacies of clearing heat, eliminating stagnation and reducing swelling, and the dahurian angelica root: warm, alleviate pain, relieve swelling, bletilla striata: ping, detumescence, acesodyne, Shuhe, borneol: pacify, alleviate pain, relieve swelling, activate blood, Tianqi: pacify, activate blood, stop bleeding, resolve swelling and alleviate pain.
The traditional Chinese medicine external preparation for treating bone diseases, provided by the invention, is orally taken: pulverizing into powder, and taking with warm boiled water 2 times a day, 5-8g each time, 3 weeks as a treatment course. The external application method comprises the following steps: the bone fragment can be applied to the affected part without splint, and wrapped with medical bandage, and the medicine has fixing effect, can relieve pain within 15-30 minutes and has refreshing feeling, and can be applied for one week for 2-3 weeks. Note that: avoid moving.
According to the traditional Chinese medicine external preparation for treating bone diseases, the reasonable matching of the raw materials of all the components is beneficial to clearing heat and reducing swelling, stopping bleeding and relieving pain, and promoting blood circulation and removing blood stasis, so that the bone healing is promoted. Is suitable for use in: prolapse of lumbar intervertebral disc, cervical spondylosis, fall, sprain, traumatic injury, fracture of tendons, and hemorrhage due to knife wound.
The injury patient must have both qi and blood, the medicine can promote blood circulation to remove blood stasis, dredge the channels and collaterals, remove blood stasis and relieve pain, remove dampness and relieve pain, the channels and collaterals are in double connection with the viscera, the injury patient must have qi and blood deficiency and know that essence, qi and spirit descend, and the application of the medicine can restore primordial qi and achieve a certain curative effect of healing the channels and the collaterals and the bones.
Example 2
A traditional Chinese medicine external preparation for treating bone diseases comprises the following traditional Chinese medicine raw materials in parts by weight: 5 parts of paris rhizome, 3 parts of angelica dahurica, 5 parts of bletilla striata, 2 parts of borneol and 5 parts of pseudo-ginseng.
The rhizoma paridis is rhizoma paridis (processed with wine).
The rhizoma Bletillae is processed rhizoma Bletillae.
The application method of the traditional Chinese medicine external preparation for treating bone diseases comprises the following steps: weighing the raw medicinal materials according to the weight ratio of each component; putting the weighed raw materials of each component into a container respectively, completely crushing the raw materials into powder, putting the crushed mixed medicine into the container, and sealing.
The application method of the traditional Chinese medicine external preparation for treating bone diseases further comprises the following steps: when in use, honey or warm water is added into the mixture and stirred to form gel, and the traditional Chinese medicine external preparation for treating bone diseases is obtained.
According to the traditional Chinese medicine external preparation for treating bone diseases, the properties and effects of the used traditional Chinese medicine raw materials are as follows: paris rhizome: cool, has the efficacies of clearing heat, eliminating stagnation and reducing swelling, and the dahurian angelica root: warm, alleviate pain, relieve swelling, bletilla striata: ping, detumescence, acesodyne, Shuhe, borneol: pacify, alleviate pain, relieve swelling, activate blood, Tianqi: pacify, activate blood, stop bleeding, resolve swelling and alleviate pain.
The traditional Chinese medicine external preparation for treating bone diseases, provided by the invention, is orally taken: pulverizing into powder, and taking with warm boiled water 2 times a day, 5-8g each time, 3 weeks as a treatment course. The external application method comprises the following steps: the bone fragment can be applied to the affected part without splint, and wrapped with medical bandage, and the medicine has fixing effect, can relieve pain within 15-30 minutes and has refreshing feeling, and can be applied for one week for 2-3 weeks. Note that: avoid moving.
According to the traditional Chinese medicine external preparation for treating bone diseases, the reasonable matching of the raw materials of all the components is beneficial to clearing heat and reducing swelling, stopping bleeding and relieving pain, and promoting blood circulation and removing blood stasis, so that the bone healing is promoted. Is suitable for use in: prolapse of lumbar intervertebral disc, cervical spondylosis, fall, sprain, traumatic injury, fracture of tendons, and hemorrhage due to knife wound.
The injury patient must have both qi and blood, the medicine can promote blood circulation to remove blood stasis, dredge the channels and collaterals, remove blood stasis and relieve pain, remove dampness and relieve pain, the channels and collaterals are in double connection with the viscera, the injury patient must have qi and blood deficiency and know that essence, qi and spirit descend, and the application of the medicine can restore primordial qi and achieve a certain curative effect of healing the channels and the collaterals and the bones.
The present invention has been described in detail, and the principle and embodiments of the present invention are explained herein by using specific examples, which are only used to help understand the method and the core idea of the present invention; meanwhile, for a person skilled in the art, according to the idea of the present invention, there may be variations in the specific embodiments and the application scope, and in summary, the content of the present specification should not be construed as a limitation to the present invention.
From the above description of the embodiments, it will be apparent to those skilled in the art that the present invention may be practiced. Of course, the above listed cases are only examples, and the present invention is not limited thereto. It should be understood by those skilled in the art that other modifications or simplifications according to the technical solution of the present invention may be appropriately applied to the present invention and should be included in the scope of the present invention.
Claims (6)
1. The traditional Chinese medicine external preparation for treating bone diseases is characterized by comprising the following traditional Chinese medicine raw materials in parts by weight: 5-8 parts of paris rhizome, 3-6 parts of angelica dahurica, 3-5 parts of bletilla striata, 2-4 parts of borneol and 5-8 parts of pseudo-ginseng.
2. The traditional Chinese medicine external preparation for treating bone diseases according to claim 1, which is characterized by comprising the following traditional Chinese medicine raw materials in parts by weight: 5 parts of paris rhizome, 3 parts of angelica dahurica, 5 parts of bletilla striata, 2 parts of borneol and 5 parts of pseudo-ginseng.
3. The external traditional Chinese medicine preparation for treating bone diseases according to claim 1 or 2, wherein the manyleaf paris rhizome is wine-processed manyleaf paris rhizome.
4. The external traditional Chinese medicine preparation for treating bone diseases according to claim 1 or 2, wherein the bletilla striata is prepared bletilla striata.
5. The use method of the external traditional Chinese medicine preparation for treating bone diseases according to any one of claims 1 to 4, which comprises the following steps: weighing the raw medicinal materials according to the weight ratio of each component; putting the weighed raw materials of each component into a container respectively, completely crushing the raw materials into powder, putting the crushed mixed medicine into the container, and sealing.
6. The use method of the external traditional Chinese medicine preparation for treating bone diseases according to claim 5, characterized by further comprising the steps of: when in use, honey or warm water is added into the mixture and stirred to form gel, and the traditional Chinese medicine external preparation for treating bone diseases is obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010518591.7A CN111544525A (en) | 2020-06-09 | 2020-06-09 | Traditional Chinese medicine external preparation for treating bone diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010518591.7A CN111544525A (en) | 2020-06-09 | 2020-06-09 | Traditional Chinese medicine external preparation for treating bone diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111544525A true CN111544525A (en) | 2020-08-18 |
Family
ID=71997086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010518591.7A Pending CN111544525A (en) | 2020-06-09 | 2020-06-09 | Traditional Chinese medicine external preparation for treating bone diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111544525A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097625A (en) * | 1994-06-06 | 1995-01-25 | 杨家强 | The compositions of treatment bony spur and cervical spondylosis and the application in plaster is made thereof |
| CN1723928A (en) * | 2005-07-07 | 2006-01-25 | 云南省药物研究所 | External use medicinal composition for treating swelling paint |
-
2020
- 2020-06-09 CN CN202010518591.7A patent/CN111544525A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097625A (en) * | 1994-06-06 | 1995-01-25 | 杨家强 | The compositions of treatment bony spur and cervical spondylosis and the application in plaster is made thereof |
| CN1723928A (en) * | 2005-07-07 | 2006-01-25 | 云南省药物研究所 | External use medicinal composition for treating swelling paint |
Non-Patent Citations (1)
| Title |
|---|
| 杨庆秋等: "云南白药促进骨缺损修复及引导性骨再生的实验研究", 《中国矫形外科杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102335326B (en) | Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain | |
| CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
| CN101703757B (en) | Plaster for reuniting fractured tendons and bones and activating blood, and preparation method thereof | |
| CN101234153B (en) | Externally-applied medicament for treating bone fracture | |
| CN100484538C (en) | Upper, middle and lower part soup, and method for making same | |
| CN104274667A (en) | Traditional Chinese medicine for treating fractures and traumatic wounds | |
| CN111544525A (en) | Traditional Chinese medicine external preparation for treating bone diseases | |
| CN106729225A (en) | A kind of active pain relieving emplastrum and preparation method thereof | |
| CN102274380A (en) | External applied medicine for treating burn and scalding | |
| CN105497333A (en) | Medicinal liquor for treating fracture | |
| CN104940501A (en) | Drug used for treating injuries from falls and uncontrollable bleeding | |
| CN101317942B (en) | Bone-setting alcohol | |
| CN102499963B (en) | Traditional Chinese medicine compound for treating fracture | |
| CN101804158B (en) | Paste for traumatic injuries | |
| CN102743550B (en) | Medicine composition for accelerating healing after fracture surgery, preparation method and application | |
| CN103251724B (en) | External plaster for treating bone injuries and preparation method thereof | |
| CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
| CN103417944A (en) | Swelling diminishing, blood activating and fracture healing ointment and method for manufacturing same | |
| CN102552610A (en) | Chinese medicinal composition for treating bone fracture | |
| CN116808132A (en) | Traditional Chinese medicine composition and application thereof | |
| CN107982363A (en) | Chinese medicine composition for swelling and pain relieving | |
| CN107308233A (en) | Pharmaceutical composition for treating Bone and joint trauma and soft-tissue trauma | |
| CN114558087A (en) | External application medicine for treating bone fracture | |
| CN106421255A (en) | Topical traditional Chinese composition and its application | |
| CN112386648A (en) | Liquid medicine for setting bones and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |